LABGENOMICS CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,695 KRW | -0.55% |
|
-2.00% | -30.09% |
LabGenomics Co., Ltd is a Korea-based company engaged in the provision of in vitro diagnostic (IVD) services. The Company mainly provides IVD services, including general diagnostic check services, molecular diagnostic check services, and research and development services. The Companyâs IVD products include deoxyribonucleic acid (DNA) chips, polymerase chain reaction (PCR) kits and others. It also provides examination for breast cancer and colorectal cancer, biosensor for point of care testing (POCT) and others. It also provides healthy food.
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -30.09% | 147M | |
| -16.58% | 8.44B | |
| +54.07% | 3.96B | |
| -37.54% | 2.52B | |
| -10.51% | 2.44B | |
| -8.17% | 2.22B | |
| -4.20% | 1.98B | |
| -18.24% | 1.58B | |
| -36.41% | 1.3B | |
| +2.19% | 1.05B |
- Stock Market
- Equities
- A084650 Stock
- Funds and ETFs LabGenomics Co., Ltd.